Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

NCT00027300

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • East Bay Region Associates in Neurology Berkeley, California, United States
  • UC Davis School of Medicine, Department of Neurology Davis, California, United States
  • Yale University School of Medicine, Department of Neurology New Haven, Connecticut, United States
View all 53 locations
View Trial Details
Completed

Efficacy and Safety of GTR in Comparison to Copaxone®

NCT01489254

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Synthon investigational site 112 Irvine, California, United States
  • Synthon investigational site 120 Port Charlotte, Florida, United States
  • Synthon investigational site 130 Sunrise, Florida, United States
  • Synthon investigational site 107 Elk Grove Village, Illinois, United States
View all 133 locations
View Trial Details
Completed

Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis

NCT02090413

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Research Site Cork, Ireland
  • Research Site Dublin, Ireland
  • Research Site Dublin, Ireland
  • Research Site Dublin, Ireland
View all 21 locations
View Trial Details
Completed

Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment

NCT01285401

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Vienna, Austria
  • Research Site Esbjerg, Denmark
  • Research Site Glostrup Municipality, Denmark
  • Research Site Sønderborg, Denmark
View all 38 locations
View Trial Details
Completed

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.

NCT01808885

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Timone University Hospital, Neurology Department, UMR CRMBM CNRS 6612 Marseille, France
  • CHU Reims, Maison Blanche Hospital, Neurology Department & University of Reims Reims, France
  • CHU Pontchaillou, Neurology Department Rennes, France
View Trial Details
Completed

Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

NCT01310166

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ostfildern, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Altenholz-Stift, Germany
  • Novartis Investigative Site Andernach, Germany
  • Novartis Investigative Site Celle, Germany
View all 61 locations
View Trial Details
Completed

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

NCT01116427

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • St. Josephs Hospital and Medical Center - Barrow Neurology Phonix, Arizona, United States
  • Jordan Research and Education Institute (REDI): Alta Bates Summit Medical Center Berkeley, California, United States
  • University of Southern California - Keck School of Medicine Los Angeles, California, United States
  • Newport Beach Clinical Research Associates, Inc. Newport Beach, California, United States
View all 21 locations
View Trial Details
Completed

Dose-finding Study of MT-1303

NCT01742052

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Brussels, Belgium
  • Research Site Sofia, Bulgaria
  • Research Site Edmonton, Canada
  • Research Site Zagreb, Croatia
View all 18 locations
View Trial Details

Related conditions